Wedbush Securities Inc. increased its stake in Medtronic PLC (NYSE:MDT) by 28.3% in Q3, now holding 45,798 shares valued at $4.36 million, contributing to institutional investors owning 82.06% of the company. Medtronic surpassed Q3 estimates with $1.36 EPS and $8.96 billion in revenue, and has issued FY2026 guidance, maintaining a “Moderate Buy” consensus rating with a $111.21 average price target. The medical technology company also offers a quarterly dividend of $0.71 per share, equating to an annualized yield of approximately 2.8%, and has a market capitalization of $129.6 billion.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Wedbush Securities Inc. Grows Position in Medtronic PLC $MDT
Wedbush Securities Inc. increased its stake in Medtronic PLC (NYSE:MDT) by 28.3% in Q3, now holding 45,798 shares valued at $4.36 million, contributing to institutional investors owning 82.06% of the company. Medtronic surpassed Q3 estimates with $1.36 EPS and $8.96 billion in revenue, and has issued FY2026 guidance, maintaining a “Moderate Buy” consensus rating with a $111.21 average price target. The medical technology company also offers a quarterly dividend of $0.71 per share, equating to an annualized yield of approximately 2.8%, and has a market capitalization of $129.6 billion.